Tenofovir Reduces Morbidity and Mortality in Patients With Spontaneous Reactivation of Hepatitis B Presenting as Acute-on-chronic Liver Failure (ACLF): A Randomized Placebo Controlled Trial
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Reduction in HBV DNA levels, survival
3 Month
Yes
Shiv K Sarin, MD,DM
Principal Investigator
G.B. Pant Hospital, New Delhi, India
India: Drugs Controller General of India
Hitendra garg
NCT01074645
November 2007
October 2009
Name | Location |
---|